Moving from efficacy to effectiveness: budesonide multimatrix in ulcerative colitis

類似資料

• Is tofacitinib a game-changing drug for ulcerative colitis?
  著者:: Magro, Fernando, 等
  出版事項: (2020)
• Predictors of Inadequate Response to Budesonide Multimatrix in Real-World Patients with Ulcerative Colitis
  著者:: Greenberg, Sydney, 等
  出版事項: (2019)
• Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
  著者:: Rubin, David T., 等
  出版事項: (2017)
• Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
  著者:: Rubin, David T, 等
  出版事項: (2017)
• Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis
  著者:: Iborra, Marisa, 等
  出版事項: (2014)